Boehringer Ingelheim Venture Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 17

Professionals

  • Investments
  • 120

  • Portfolio
  • 46

  • Exits
  • 28

Exits

Boehringer Ingelheim Venture Fund General Information

Company Description

Founded in 2010, Boehringer Ingelheim Venture Fund is a corporate venture capital arm of Boehringer Ingelheim based in Ingelheim am Rhein, Germany. The firm seeks to invest in digital health, immune-oncology, regenerative medicine, and other technology sector startups.

Business Details

Website
www.boehringer-ingelheim-venture.com
Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • Binger Strasse 173
  • 55216 Ingelheim am Rhein
  • Germany

Boehringer Ingelheim Venture Fund Investments (120)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
SRTD Biotech 09-Nov-2026 Seed Round Drug Discovery Pre-Clinical Trials
Cloverleaf Bio 08-Sep-2026 Drug Discovery Pre-Clinical Trials
Centauri Therapeutics 01-Jul-2026 Drug Discovery Generating Revenue
Brainomix 05-May-2026 Diagnostic Equipment Generating Revenue
Tacalyx 29-Apr-2026 Drug Discovery Pre-Clinical Trials
TECregen 08-Jan-2026 Drug Discovery Pre-Clinical Trials
STRM.BIO 07-Jan-2026 Drug Discovery Pre-Clinical Trials
Smartbax 06-Aug-2025 Drug Discovery Pre-Clinical Trials
EvlaBio 07-Jul-2025 Seed Round Drug Discovery Generating Revenue
Nuevocor 06-May-2025 Later Stage VC Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 120 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim Venture Fund Exits (28)

Company Name Exit Date Exit Type Exit Size
etherna 12-Oct-2026 Merger/Acquisition
Agomab Therapeutics 06-Feb-2026
ImCheck Therapeutics 15-Dec-2025
Sentien (Drug Discovery) 29-Sep-2025
TigaTx 13-Mar-2025
Dirico 06-Dec-2024
Cardior 25-Mar-2024
Metabomed 08-Feb-2024
Delonix Bioworks 31-Dec-2023 Merger/Acquisition
T3 Pharmaceuticals 22-Nov-2023 Merger/Acquisition
You’re viewing 10 of 28 exits. Get the full list »

Boehringer Ingelheim Venture Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Boehringer Ingelheim Venture Fund Co-Investors (121)

Name With Exits Lead Partner Series Industry
High-Tech Gründerfonds 9 Series chart Industry bar
Kurma Partners Series chart Industry bar
AdBio partners Series chart Industry bar
NRW BANK Series chart Industry bar
Wellington Partners Series chart Industry bar
You’re viewing 5 of 121 co-investors. Get the full list »

Boehringer Ingelheim Venture Fund Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Speransa Therapeutics Frankfurt am Main, Germany 2021

Boehringer Ingelheim Venture Fund FAQs

  • What is Boehringer Ingelheim Venture Fund?

    Founded in 2010, Boehringer Ingelheim Venture Fund is a corporate venture capital arm of Boehringer Ingelheim based in Ingelheim am Rhein, Germany.

  • When was Boehringer Ingelheim Venture Fund founded?

    Boehringer Ingelheim Venture Fund was founded in 2010.

  • Where is Boehringer Ingelheim Venture Fund headquartered?

    Boehringer Ingelheim Venture Fund is headquartered in Ingelheim am Rhein, Germany.

  • What is Boehringer Ingelheim Venture Fund's total asset value?

    Boehringer Ingelheim Venture Fund has around in total assets under management.

  • How many investments has Boehringer Ingelheim Venture Fund made?

    Boehringer Ingelheim Venture Fund has made 120 investments.

  • What has Boehringer Ingelheim Venture Fund invested in?

    Boehringer Ingelheim Venture Fund has made numerous investments in companies like SRTD Biotech, Cloverleaf Bio, and Centauri Therapeutics within the Drug Discovery industry.

  • What has Boehringer Ingelheim Venture Fund invested in recently?

    Boehringer Ingelheim Venture Fund's latest investment was on 09-Nov-2026 in SRTD Biotech, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process